| Dr Kenneth Bunch, MD | |
|
4700 Seton Center Pkwy, Suite 200, Austin, TX 78759-5295 | |
| (512) 439-1000 | |
| (512) 439-1081 |
| Full Name | Dr Kenneth Bunch |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 22 Years |
| Location | 4700 Seton Center Pkwy, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871543405 | NPI | - | NPPES |
| 191447502 | Medicaid | TX | |
| 50059281 | Other | CAPITAL BLUE CROSS/KHPC | |
| P00480719 | Other | TX | MEDICARE RAILROAD |
| P00477942 | Other | TX | MEDICARE RAILROAD |
| 2708299000 | Other | INDEPENDENCE BLUE CROSS/K | |
| 1851399 | Other | HIGHMARK BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD428492 (Pennsylvania) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | M7072 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ortholonestar Pllc | 9931529062 | 364 |
News Archive
Velocity Pharmaceutical Development, LLC ("VPD") and Remeditex Ventures, LLC ("Remeditex") announced today the signing of a collaboration agreement. Under this agreement, VPD and Remeditex will jointly evaluate pharmaceutical development opportunities for management by the VPD development team and potential funding from Velocity Pharmaceutical Holdings, LLC and Remeditex.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
› Verified 9 days ago
| Entity Name | Texas Orthopedics Sports & Rehabilitation Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346244688 PECOS PAC ID: 7618878893 Enrollment ID: O20040421000646 |
News Archive
Velocity Pharmaceutical Development, LLC ("VPD") and Remeditex Ventures, LLC ("Remeditex") announced today the signing of a collaboration agreement. Under this agreement, VPD and Remeditex will jointly evaluate pharmaceutical development opportunities for management by the VPD development team and potential funding from Velocity Pharmaceutical Holdings, LLC and Remeditex.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
› Verified 9 days ago
| Entity Name | Ortholonestar Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942860176 PECOS PAC ID: 9931529062 Enrollment ID: O20201012001450 |
News Archive
Velocity Pharmaceutical Development, LLC ("VPD") and Remeditex Ventures, LLC ("Remeditex") announced today the signing of a collaboration agreement. Under this agreement, VPD and Remeditex will jointly evaluate pharmaceutical development opportunities for management by the VPD development team and potential funding from Velocity Pharmaceutical Holdings, LLC and Remeditex.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Bunch, MD 4700 Seton Center Pkwy, Suite 200, Austin, TX 78759-5295 Ph: (512) 439-1000 | Dr Kenneth Bunch, MD 4700 Seton Center Pkwy, Suite 200, Austin, TX 78759-5295 Ph: (512) 439-1000 |
News Archive
Velocity Pharmaceutical Development, LLC ("VPD") and Remeditex Ventures, LLC ("Remeditex") announced today the signing of a collaboration agreement. Under this agreement, VPD and Remeditex will jointly evaluate pharmaceutical development opportunities for management by the VPD development team and potential funding from Velocity Pharmaceutical Holdings, LLC and Remeditex.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
› Verified 9 days ago
Mrs. Kaycee Mcelwee, PT, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 706a W Ben White Blvd, Austin, TX 78704 Phone: 512-441-5100 Fax: 512-441-5108 | |
Enrique B Pena, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1004 W 32nd St Ste 200, Austin, TX 78705 Phone: 512-324-3580 Fax: 512-324-3581 | |
Dr. Robert Lee, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-544-7111 | |
Dr. Lori Beth Wasserburger, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2525 Wallingwood Dr, Bldg 1, Ste 212, Austin, TX 78746 Phone: 512-358-0500 Fax: 512-358-0520 | |
Faheem Mahomed, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1601 Trinity St, Austin, TX 78712 Phone: 512-913-5011 | |
Darius N. Clarke, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 823 Congress Ave Ste 150-518, Austin, TX 78701 Phone: 888-380-0988 Fax: 289-236-3022 | |
Joseph A. Volpe, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 12221 N Mopac Expy, Austin, TX 78758 Phone: 512-901-4011 Fax: 512-901-3950 |